PDZ domain-containing protein 2 (PDZD2)

**PDZ domain-containing protein 2** (PDZD2) is a multi-PDZ scaffold/adaptor protein found predominantly in the endoplasmic reticulum and secreted extracellularly as a processed peptide containing two PDZ domains[1]. PDZD2 is ubiquitously expressed and is homologous to pro-interleukin-16, suggesting similar regulatory processing. Its primary function appears to be organizing and anchoring membrane-associated protein complexes, especially at the plasma membrane and endomembranes. Proteolytic cleavage of PDZD2 generates a secreted fragment, implying roles both inside the cell (as an organizer of signaling complexes) and potentially outside the cell (as a signaling molecule), though extracellular functions remain underexplored[1][7]. PDZD2 is not a canonical drug target (such as a receptor, ion channel, enzyme, or transporter), and its clinical significance is mainly limited to its role as a structural/scaffolding protein crucial for signal transduction and spatial organization of signaling machinery[4][7]. There are no approved drugs or experimental ligands known to directly bind or modulate PDZD2 in a therapeutic context, and consequently, no documented mechanism of action for any drugs. PDZD2 is not a validated clinical biomarker for patient selection or effect monitoring, and there are no documented safety concerns associated with its direct modulation as it is not currently a therapeutic target. The PDZ domain itself is a protein-protein interaction module found in many scaffold proteins. These domains mediate the assembly of signaling complexes by recognizing short C-terminal motifs of partner proteins, thus playing a pivotal role in subcellular localization and signaling specificity[4][7]. PDZD2, like other multi-PDZ proteins, may participate in tissue-specific functions and local protein networks, but direct pathological roles or drug interactions are not established[1][4][7].

Other names

PAPINAIPCPIN1